Alzheimer's disease (AD) is a progressive neurodegenerative disorder greatly accompanied by oxidative stress and acetylcholine reduction in synaptic cleft that leads to dementia. Previously approved there is correlation between nucleus basalis of Meynert (NBM) degeneration and loss of memory, learning ability and thought. The aim of this study was to investigate improving effects of Echium amoenum aqueous extract on memory deficient, pathophysiological and oxidative damages imposed by NBM lesion in rats as documented AD model. Results showed NBM destruction causes hash oxidative stress that possibly leads to neurodegeneration in hippocampus tissue. Orally administration of plant extract significantly reduced oxidative stress by reactive molecules scavenging that resulted to decrease lipid peroxidation also. Plant extract treatment inhibited acetylcholine esterase enzyme (more than 5 folds) in hippocampus tissue related to NBM lesioned rats. Histological studies approved NBM lesion causes harsh neurodegeneration in hippocampus tissue possibly by acetylcholine reduction that was compensated by plant extract protective effects. Interestingly improving effects of plant in molecular level causes improved spatial learning ability in Morris water maze test. By considering pathophysiological and molecular similarities between AD and NBM lesion model, E. amoenum could be used as a therapeutic adjuvant in patients suffering from Alzheimer or similar cognitive disorders.
AkhondzadehS., NoroozianM., MohammadiM., OhadiniaS., JamshidiA. and KhaniM., Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial, J Neurol Neurosurg Psychiatry74(7) (2003), 863–866. doi:10.1136/jnnp.74.7.863.
2.
AkramM. and NawazA., Effects of medicinal plants on Alzheimer's disease and memory deficits, Neural Regen Res12(4) (2017), 660–670. doi:10.4103/1673-5374.205108.
ArendtT., BiglV., ArendtA. and TennstedtA., Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease, Acta Neuropathol61(2) (1983), 101–108. doi:10.1007/BF00697388.
Bromley-BritsK., DengY. and MorrisS.W., Water maze test for learning and memory deficits in Alzheimer's disease model mice, J Vis Exp20(53) (2011), 2920.
7.
BuegeJ.A. and AustS.D., Microsomal lipid, peroxidation, in: Methods in Enzymology, FlesicherS. and PackerL., eds, Academic Press, New-York, 1978.
8.
Davoodian-DehkordiA., HojjatiM., YousefiM., MoshtaghiA., RahimianR. and RafieianM., The effect of hydro-alcoholic extract of dried Ficus carica on spatial learning and memory in mice, J Shahrekord Univ Med Sci12 (2011), 1–7.
9.
DeepaP. and KannappanN., Comparative in vitro antioxidant studies of aqueous solution of formulated poly herbal formulation with marketed preparation, Der Pharm Lett4 (2012), 1515–1517.
10.
DhandapaniS., SubramanianV.R., RajagopalS. and NamasivayamN., Hypolipidemic effects of cuminum cyminuml on alloxan-induced diabetic rats, Pharmacol Res46 (2002), 251–255. doi:10.1016/S1043-6618(02)00131-7.
11.
DhandapaniS., SubramanianV.R., RajagopalS. and NamasivayamN., Hypolipidemic effects of Cuminum cyminum L. on alloxan-induced diabetic rats, Pharmacol Res46 (2002), 251–255. doi:10.1016/S1043-6618(02)00131-7.
12.
EidiM., EidiA. and BaharM., Effects of Salvia officinalis L. (sage) leaves on memory retention and its interaction with the cholinergic system in rats, Nutrition22(3) (2006), 321–326. doi:10.1016/j.nut.2005.06.010.
13.
Ferreira-VieiraT.H., GuimaraesI.M., SilvaF.R. and RibeiroF.M., Alzheimer's disease: Targeting the cholinergic system, Curr Neuropharmacol14(1) (2016), 101–115. doi:10.2174/1570159X13666150716165726.
14.
HooperD. and FieldH., Useful Plants and Drugs of Iran and Iraq, Field Museum of Natural History, Chicago, USA, 1937.
15.
KomuraJ. and SakamotoS., Short-term oral administration of several manganese compounds in mice: Physiological and behavioral alterations caused by different forms of manganese, Bull Environ Contam Toxicol46(6) (1991), 921–928. doi:10.1007/BF01689739.
16.
KumarA., NishaC.M., SilakariC., SharmaI., AnushaK., GuptaN., NairP., TripathiT. and KumarA., Current and novel therapeutic molecules and targets in Alzheimer's disease, J Formos Med Assoc115(1) (2016), 3–10. doi:10.1016/j.jfma.2015.04.001.
17.
LebelC.P., IschiropoulosH. and BondyS.C., Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress, Chem Res Toxicol5 (1992), 227–231. doi:10.1021/tx00026a012.
18.
LiJ., O W., LiW., JiangZ.G. and GhanbariH.A., Oxidative stress and neurodegenerative disorders, Int J Mol Sci14(12) (2013), 24438–24475. doi:10.3390/ijms141224438.
19.
MehrabaniM., GhassemiN., SajjadiE., GhannadiA. and Shams-ArdakaniM., Main phenolic compound of petals of Echium amoenum Fisch and C.A. Mey, a famous medicinal plant of Iran, Daru13 (2005), 65–69.
20.
MufsonE.J., CountsS.E., PerezS.E. and GinsbergS.D., Cholinergic system during the progression of Alzheimer's disease: Therapeutic implications, Expert Rev Neurother8(11) (2008), 1703–1718. doi:10.1586/14737175.8.11.1703.
21.
Muñoz-EspadaA.C. and WatkinsB.A., Cyanidin attenuates PGE2 production and cyclooxygenase-2 expression in LNCaP human prostate cancer cells, J Nutr Biochem17 (2006), 589–596. doi:10.1016/j.jnutbio.2005.10.007.
OrhanI. and AslanM., Appraisal of scopolamine-induced antiamnesic effect in mice and in vitro antiacetylcholinesterase and antioxidant activities of some traditionally used Lamiaceae plants, J Ethnopharmacol122(2) (2009), 327–332. doi:10.1016/j.jep.2008.12.026.
24.
PariharM.S. and HemnaniT., Alzheimer's disease pathogenesis and therapeutic interventions, J Clin Neurosci11(5) (2004), 456–467. doi:10.1016/j.jocn.2003.12.007.
25.
PerryG., CashA.D. and SmithM.A., Alzheimer disease and oxidative stress, J Biomed Biotechnol2(3) (2002), 120–123. doi:10.1155/S1110724302203010.
26.
PrasherV.P., Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population, Int J Geriatr Psychiatry19(6) (2004), 509–515. doi:10.1002/gps.1077.
27.
RabieiZ., HojjatiM., Rafieian-KopaeiaM. and AlibabaeiZ., Effect of Cyperus rotundus tubers ethanolic extract on learning and memory in animal model of Alzheimer, Biomed Aging Pathol3 (2013), 185–191. doi:10.1016/j.biomag.2013.08.006.
28.
RanjbarA., KhoramiS., SafarabadiM., ShahmoradiA., MalekiradA.A., VakilianK., MandegaryA. and AbdollahiM., Antioxidant activity of Iranian Echium amoenum Fisch & C.A. Mey flower decoction in humans: a cross-sectional before/after clinical trial, Evid Based Complement Alternat Med3 (2006), 469–473. doi:10.1093/ecam/nel031.
29.
SadeghiL., TanwirF. and Yousefi BabadiV., In vitro toxicity of iron oxide nanoparticle: Oxidative damages on Hep G2 cells, Exp Toxicol Pathol67(2) (2015), 197–203. doi:10.1016/j.etp.2014.11.010.
30.
SarnyaiZ., SibilleE.L., PavlidesC., FensterR.J., McEwenB.S. and TothM., Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1A receptors, Proc Natl Acad Sci USA97 (2000), 14731–14736. doi:10.1073/pnas.97.26.14731.
31.
WenkG.L., Animal models of Alzheimer's disease: Are they valid and useful?, Acta Neurobiol Exp (Wars)50(4–5) (1990), 219–223.
